Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:45 PM
Ignite Modification Date:
2025-12-24 @ 9:45 PM
NCT ID:
NCT07288632
Eligibility Criteria:
Inclusion Criteria:
* • Patients aged 18 years or older,
* Cytological or histological confirmation of NSCLC,
* Locally advanced or metastatic disease (Stage III-IV),
* Patients starting a new anticancer treatment for locally advanced/metastatic disease (first or further line of treatment),
* Testing for oncogenic (EGFR, KRAS, ALK, ROS1 and PD-1/PD-L1) profile performed,
* Written informed consent
Exclusion Criteria:
* • Patients received surgery or radiotherapy for lung cancer within the past 3 months before recruitment or chemotherapy within the past 1 months before recruitment,
* Patients with a history of VTE after cancer diagnosis or evidence of VTE events at enrollment
* Continuative use of anticoagulant drugs for any indication (atrial fibrillation or previous VTE)
* ECOG performance profile 3 or 4
* Life expectancy of less than 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07288632
Study Brief:
Protocol Section:
NCT07288632